151 related articles for article (PubMed ID: 9331070)
1. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract][Full Text] [Related]
2. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.
Su GH; Hilgers W; Shekher MC; Tang DJ; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Jun; 58(11):2339-42. PubMed ID: 9622070
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
[TBL] [Abstract][Full Text] [Related]
4. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
[TBL] [Abstract][Full Text] [Related]
8. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors.
Wang L; Pan Y; Dai JL
Oncogene; 2004 Aug; 23(35):5978-85. PubMed ID: 15184866
[TBL] [Abstract][Full Text] [Related]
9. High expression and activation of MAP kinase-activated protein kinase 2 in cardiac muscle cells.
Zu YL; Ai Y; Gilchrist A; Maulik N; Watras J; Sha'afi RI; Das DK; Huang CK
J Mol Cell Cardiol; 1997 Aug; 29(8):2159-68. PubMed ID: 9281447
[TBL] [Abstract][Full Text] [Related]
10. Impaired TCR-mediated apoptosis and Bcl-XL expression in T cells lacking the stress kinase activator SEK1/MKK4.
Nishina H; Radvanyi L; Raju K; Sasaki T; Kozieradzki I; Penninger JM
J Immunol; 1998 Oct; 161(7):3416-20. PubMed ID: 9759859
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
[TBL] [Abstract][Full Text] [Related]
13. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
14. Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages.
Winston BW; Chan ED; Johnson GL; Riches DW
J Immunol; 1997 Nov; 159(9):4491-7. PubMed ID: 9379049
[TBL] [Abstract][Full Text] [Related]
15. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress- and cytokine-stimulated monocytes and epithelial cells.
Cuenda A; Alonso G; Morrice N; Jones M; Meier R; Cohen P; Nebreda AR
EMBO J; 1996 Aug; 15(16):4156-64. PubMed ID: 8861944
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the coding sequences of MEK-1 and MEK-2 genes in human lung cancer cell lines.
Bansal A; Ramirez RD; Minna JD
Oncogene; 1997 Mar; 14(10):1231-4. PubMed ID: 9121773
[TBL] [Abstract][Full Text] [Related]
17. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
[TBL] [Abstract][Full Text] [Related]
18. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways.
Takekawa M; Posas F; Saito H
EMBO J; 1997 Aug; 16(16):4973-82. PubMed ID: 9305639
[TBL] [Abstract][Full Text] [Related]
19. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development.
Swat W; Fujikawa K; Ganiatsas S; Yang D; Xavier RJ; Harris NL; Davidson L; Ferrini R; Davis RJ; Labow MA; Flavell RA; Zon LI; Alt FW
Immunity; 1998 May; 8(5):625-34. PubMed ID: 9620683
[TBL] [Abstract][Full Text] [Related]
20. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research.
Robinson VL; Hickson JA; Vander Griend DJ; Dubauskas Z; Rinker-Schaeffer CW
Clin Exp Metastasis; 2003; 20(1):25-30. PubMed ID: 12650604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
